To elucidate the molecular mechanism underlying the action of PA within TGF-β1 treatment, we investigated whether it alters the phosphorylation of the SMAD3-STAT3 signaling involved in renal fibrosis. The gene discussed is STAT3; the disease is renal fibrosis.